Tag: Rubicon Minerals Corp. (USA)

  • Small Cap Bullish Mover: Career Education Corp. (NASDAQ:CECO), 21Vianet Group Inc (NASDAQ:VNET), Rubicon Minerals Corp. (USA) (NYSEMKT:RBY), Tarena International Inc (ADR) (NASDAQ:TEDU), Portola Pharmaceuticals Inc (NASDAQ:PTLA)

    On June 3, Career Education Corp. (NASDAQ:CECO) announced that board member Ron McCray was elected Chairman by the company’s Board of Directors. McCray replaces David Devonshire, who remains a member of the Board of Directors, but who did not seek another term as Chairman so he could better attend to personal matters.  Career Education Corp. (NASDAQ:CECO) net profit margin is -21.90% and weekly performance is 7.88%. On last trading day company shares ended up $5.34. Analysts mean target price for the company is $5.50. Career Education Corp. (NASDAQ:CECO) distance from 50-day simple moving average (SMA50) is -8.04%.

     

    21Vianet Group Inc (NASDAQ:VNET) announced after the close Wednesday that it has priced an offering of RMB2 billion in aggregate principal amount of the RMB denominated bonds due 2017 at an interest rate of 6.875% per annum. 21Vianet Group Inc (NASDAQ:VNET) shares advanced 6.04% in last trading session and ended the day on $29.31. VNET Gross Margin is 26.50% and its return on assets is –3.80%. 21Vianet Group Inc (NASDAQ:VNET) quarterly performance is 24.62%.

     

    On Jun 13, 2014, Rubicon Minerals Corp. (USA) (NYSEMKT:RBY)  announces that Institutional Shareholder Services Inc. (“ISS“) and Glass Lewis & Co., two leading independent proxy firms, have recommended that shareholders of Rubicon vote “For” all of the matters proposed in the information circular (the “Circular“) of Rubicon dated May 16, 2014 in connection with the Annual General and Special Meeting (the “Meeting“) of the Company to be held on Wednesday, June 25, 2014 at 2:00 p.m.  Rubicon Minerals Corp. (USA) (NYSEMKT:RBY) shares moved up 5.69% in last trading session and was closed at $1.30, while trading in range of $1.23 – $1.31. Rubicon Minerals Corp. (USA) (NYSEMKT:RBY) year to date (YTD) performance is 51.16%.

     

    On 13 June, Tarena International Inc (ADR) (NASDAQ:TEDU) Signes cooperation agreements with six universities and colleges in Jiangsu Province, namely Yangzhou University, Jiangsu Normal University, Huaihai Institute of Technology, Huaiyin Institute of Technology, Taihu University of Wuxi, and Xuhai College. And China University of Mining and Technology to offer joint major programs in software engineering and computer science. Pursuant to cooperation agreements, these six universities and colleges will offer their students options to enroll in joint major programs with Tarena and include Tarena’s selected courses in their standard undergraduate curriculum. In return, Tarena will receive the portion of students’ tuition that are attributable to Tarena courses. Tarena International Inc (ADR) (NASDAQ:TEDU) ended the last trading day at $11.96. Company weekly volatility is calculated as 7.78% and price to cash ratio as 23.21. Tarena International Inc (ADR) (NASDAQ:TEDU) showed a positive weekly performance of 10.33%.

    On June 11, 2014, Portola Pharmaceuticals Inc (NASDAQ:PTLA) announced that a Phase 2 proof-of-concept study in healthy volunteers demonstrated that andexanet alfa, a potential first-in-class Factor Xa inhibitor antidote, immediately reversed the anticoagulation activity of enoxaparin, a low molecular weight heparin and standard of care in venous thromboembolism prevention. Andexanet alfa was well tolerated with no serious adverse events reported. Detailed data will be presented during both oral and poster sessions at the 60th Scientific and Standardization Committee (SSC) Meeting of the International Society on Thrombosis and Haemostasis (ISTH), which is taking place from June 23-26 in Milwaukee, Wis. Portola is developing andexanet alfa, an FDA-designated breakthrough therapy, to reverse the anticoagulation activity of Factor Xa inhibitor-treated patients who are experiencing a major bleeding episode or who require emergency surgery. Portola Pharmaceuticals Inc (NASDAQ:PTLA) shares moved up 7.31% in last trading session and was closed at $30.37, while trading in range of $27.96 – $30.58. Portola Pharmaceuticals Inc (NASDAQ:PTLA) year to date (YTD) performance is 17.94%.